Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Neoplasms 3Breast Neoplasms 3Papillomavirus Infections 2Melanoma 2Lung Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Sarcoma 1Prostatic Neoplasms 1Neuroblastoma 1Neoplasms, Nerve Tissue 1NY-ESO-1-expressing Tumors 1Leukemia, Myeloid, Acute 1Herpes Zoster 1Glioma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Condylomata Acuminata 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Anus Neoplasms 1Adenoviridae Infections 1Adenocarcinoma 1

Interventions

tremelimumab 2fludarabine 2durvalumab 2aflibercept 2Trastuzumab 2Radiotherapy 2Radiosurgery 2Cyclophosphamide 2Cisplatin 2tipifarnib 1sapropterin 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1Vaccines 1Topotecan 1Therapeutics 1Radiation 1Platinum 1Pharmacogenomic Testing 1Papillomavirus Vaccines 1Nelfinavir 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunoglobulin G 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gemcitabine 1Ganciclovir 1E6 protein, Human papillomavirus type 16 1Docetaxel 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Vulvar Neoplasms × Vaccines × Clear all
NCT05680454 2023-01-17

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Beijing Health Guard Biotechnology, Inc

Phase 1 Completed
160 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡